Sector·2 min read
Pharmaceutical Plant Fire Safety
Pharmaceutical plants combine high fire risk with very high asset value: API synthesis uses solvents such as ethanol and acetone and carries the risk of runaway reactions in reactors; powdered active ingredients can form explosive dust; GMP clean rooms, laboratories, and sensitive electronics must be protected against both water damage and contamination; vaccines and biologicals add cold-storage risk. This article covers the real fire risks in pharma/pharmaceutical plants, the measures to take, and the recommended suppression systems (clean-agent gas in clean rooms and labs, foam + containment in solvent areas, spark detection on dust lines, and aspirating very-early detection).
A-Pro Engineering
Pharmaceutical plants combine high fire risk with very high asset value: solvent and reactor risk in API production, explosive dust from powdered active ingredient, and GMP clean rooms/laboratories that need protection against both water damage and contamination. This article covers the real risks, measures, and recommended suppression systems.
Risk: high fire probability + high asset value
- Solvents (ethanol, acetone, toluene) — vapor forms an explosive mixture with air,
- Runaway reaction in a reactor — temperature/pressure rise,
- Powdered API — explosive dust,
- Clean room/lab/electronics — high-value, sensitive to water and contamination,
- Vaccine/biological cold storage — freezing + fire load.
Measure: solvent and reactor areas
- Separate, ventilated, ATEX-compliant design,
- Gas/vapor detection + flame detector,
- Foam + containment for flammable-liquid surface/spill,
- Temperature/pressure monitoring + emergency cooling in the reactor (process safety).
Measure: clean room and laboratory
Water both damages equipment and contaminates the product; so:
- Clean-agent gas (FM200/NOVEC/inert) — clean, residue-free,
- Room tightness + ventilation closing on activation,
- Aspirating very-early detection (VESDA) — catches micron particles even at high air change.
We covered clean-agent suppression in our gas suppression article and very-early detection in our data center article.
Measure: powdered active ingredient
- Closed processing + local extraction + housekeeping,
- Equipment grounding,
- Spark detection on dust transport lines.
Recommended suppression systems
| Area | Recommended system |
|---|---|
| Clean room, laboratory, sensitive electronics | Clean-agent gas (FM200/NOVEC/inert) |
| Solvent production/storage | Foam + containment + gas/flame detection |
| Dust-handling process | Spark detection-extinguishing |
| Packaging / high-rack storage | Sprinkler / ESFR |
| Vaccine/biological cold storage | Dry/preaction sprinkler |
| Early detection | Aspirating (VESDA) |
Summary
Pharma plant fire safety balances high risk with high asset value: protecting the solvent/reactor area with foam + containment + gas detection, the clean room/lab with clean-agent gas + very-early detection, dust with spark detection, and storage with sprinkler/ESFR. All are based on NFPA 30/2001/13/11 + EN 12845/BYKHY (and GMP requirements). For a related risk see our chemical storage article. At A-Pro Engineering we design clean-agent suppression, foam, spark detection, and very-early detection for pharma plants in an integrated way; contact us for your project.
This content is for information purposes. Binding design must be done on a project basis based on process type, solvent/dust character, GMP requirements, and actual facility conditions, together with NFPA 30, NFPA 2001, NFPA 13/11, EN 12845, and the current edition of BYKHY.
© 2027 A-Pro Mühendislik. This is original technical content produced by A-Pro Engineering; all rights reserved. Copying, reproducing or republishing it in whole or in part without attribution and permission is prohibited.
Frequently asked questions
What is the biggest fire risk in a pharma plant?+
The biggest risk is the solvents used in active-ingredient (API) production. Flammable liquids such as ethanol, methanol, acetone, and toluene are used intensively in synthesis, extraction, and cleaning processes; their vapors can form an explosive mixture with air. If exothermic reactions in reactors get out of control (runaway), temperature and pressure rise and can lead to fire/explosion. The second risk is explosive dust arising from handling powdered active and excipient materials. In addition, clean rooms, laboratories, and sensitive electronics are high-value and must be protected against both fire and suppression-water damage. So the risk is both a high fire probability and a high asset value.
How are solvent and reactor areas protected?+
Areas where solvents are used and stored carry a flammable-liquid fire character; they should be designed separately, ventilated, away from ignition sources, and ATEX-compliant (per explosive-atmosphere classification). Gas/vapor detection and flame detectors catch leaks and ignition early. Water alone is not enough for suppression; foam addition is used for flammable-liquid surfaces and spills, and containment (a bund) so spills do not spread. In reactors, process safety (temperature/pressure monitoring, emergency cooling, pressure relief) is an inseparable part of fire protection. These areas are compartmented separately as the highest-risk section of the facility.
Which suppression is used in clean rooms and laboratories?+
GMP clean rooms, laboratories, and sensitive analytical/electronic equipment are both high-value and sensitive to water and contamination; in these areas sprinkler water both damages equipment and contaminates the product. So clean-agent gas (FM200, NOVEC, or inert gas) is preferred; it provides a clean, residue-free suppression that does not harm electronics/product. In a clean-agent system, room tightness and closing the ventilation on activation are critical. For early detection, aspirating very-early detection (VESDA) is preferred; it catches micron-scale smoke particles even in the clean room's high air-change environment. We covered clean-agent suppression in a separate article.
How is the powdered active-ingredient risk managed?+
Powdered active ingredients (API) and excipients create fine airborne dust in weighing, mixing, granulation, and tablet-pressing processes; for some materials this dust creates an explosive atmosphere and a spark can trigger an explosion. For management, design and housekeeping that limit dust accumulation, closed processing and local extraction, equipment grounding, and spark detection on dust transport lines are applied. For some highly active materials (HPAPI), closed systems are already used, which also reduces the fire risk. Dust-handling areas are protected by handling process safety and fire protection together.
Which suppression systems are recommended in a pharma plant?+
By area: clean-agent gas (FM200/NOVEC/inert) for clean rooms, laboratories, and sensitive electronics; foam addition + containment + gas/flame detection for solvent production and storage; spark detection-extinguishing for dust-handling processes; sprinkler/ESFR for packaging and high-rack storage; freeze-resistant dry/preaction sprinkler for vaccine/biological cold storage; sprinkler in general areas. On the detection side, aspirating very-early detection (VESDA) is standard in high-value volumes. The right set is designed in an integrated way considering GMP requirements and asset value.
Which standards govern pharma plants?+
NFPA 30 for flammable-liquid (solvent) areas, NFPA 2001 for clean-agent suppression, NFPA 13/EN 12845 for high-rack storage, and NFPA 11 for foam are the basis. For dust-handling processes, dust safety approaches (NFPA 652 framework) and ATEX/explosive-atmosphere classification are considered. GMP and validation requirements determine the compatibility of the suppression system with the product and clean room. In Türkiye, design is based on these standards together with BYKHY. For related topics see our clean-agent suppression and chemical storage articles.
Related systems
Let’s discuss the right solution for your facility
Contact our engineers for a free site survey and quote within Ankara.